TRIM64C

gene
On this page

Summary

TRIM64C (tripartite motif containing 64C, HGNC:37148) is a protein-coding gene on chromosome 11p11.12, encoding Tripartite motif-containing protein 64C (A6NLI5).

Predicted to enable ubiquitin protein ligase activity. Predicted to be involved in innate immune response and regulation of gene expression. Predicted to be active in cytoplasm.

Source: NCBI Gene 646754 — RefSeq curated summary.

At a glance

  • GWAS associations: 2
  • Clinical variants (ClinVar): 97 total
  • MANE Select transcript: NM_001206631

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:37148
Approved symbolTRIM64C
Nametripartite motif containing 64C
Location11p11.12
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000214891
Ensembl biotypeprotein_coding
Entrez646754

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000617704

RefSeq mRNA: 1 — MANE Select: NM_001206631 NM_001206631

CCDS: CCDS73287

Canonical transcript exons

ENST00000617704 — 6 exons

ExonStartEnd
ENSE000015368794905635949056381
ENSE000021402274905531049055407
ENSE000021566264905870149059112
ENSE000021795994905807849058172
ENSE000037170304905714849057378
ENSE000037905344905371449054207

Expression profiles

Bgee: expression breadth tissue_specific, 2 present calls, max score 53.47.

Top tissues by expression

133 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099153.47gold quality
colonic epitheliumUBERON:000039737.20gold quality
ventricular zoneUBERON:000305336.48gold quality
cortical plateUBERON:000534336.47gold quality
bone marrow cellCL:000209236.16gold quality
ganglionic eminenceUBERON:000402335.49gold quality
skeletal muscle tissueUBERON:000113433.38gold quality
hindlimb stylopod muscleUBERON:000425232.15gold quality
bone marrowUBERON:000237131.74gold quality
muscle tissueUBERON:000238531.06gold quality
sural nerveUBERON:001548830.93gold quality
stromal cell of endometriumCL:000225529.87gold quality
monocyteCL:000057629.36gold quality
leukocyteCL:000073829.20gold quality
prefrontal cortexUBERON:000045129.04gold quality
duodenumUBERON:000211428.14gold quality
liverUBERON:000210728.04gold quality
lymph nodeUBERON:000002927.57gold quality
tonsilUBERON:000237227.05gold quality
islet of LangerhansUBERON:000000626.55gold quality
vermiform appendixUBERON:000115426.42gold quality
bloodUBERON:000017826.04gold quality
gall bladderUBERON:000211025.98gold quality
olfactory segment of nasal mucosaUBERON:000538625.89gold quality
placentaUBERON:000198725.81gold quality
urinary bladderUBERON:000125525.72gold quality
muscle of legUBERON:000138324.80gold quality
primary visual cortexUBERON:000243624.61gold quality
superior frontal gyrusUBERON:000266124.08gold quality
pancreasUBERON:000126424.01gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes3.28

Regulation

Is transcription factor: no

Cross-species orthologs

0 orthologs

Paralogs (80): MID2 (ENSG00000080561), TRIM9 (ENSG00000100505), MID1 (ENSG00000101871), MEFV (ENSG00000103313), TRIM35 (ENSG00000104228), TRIM14 (ENSG00000106785), TRIM37 (ENSG00000108395), TRIM2 (ENSG00000109654), TRIM3 (ENSG00000110171), TRIM38 (ENSG00000112343), TRIM62 (ENSG00000116525), TRIM67 (ENSG00000119283), TRIM32 (ENSG00000119401), BSPRY (ENSG00000119411), TRIM25 (ENSG00000121060), TRIM6 (ENSG00000121236), TRIM24 (ENSG00000122779), TRIM51 (ENSG00000124900), TRIM28 (ENSG00000130726), TRIM21 (ENSG00000132109), TRIM5 (ENSG00000132256), TRIM22 (ENSG00000132274), TRIM47 (ENSG00000132481), TRIM45 (ENSG00000134253), TRIM29 (ENSG00000137699), TRIM54 (ENSG00000138100), PML (ENSG00000140464), TRIM65 (ENSG00000141569), TRIM43B (ENSG00000144010), TRIM43 (ENSG00000144015), TRIM7 (ENSG00000146054), TRIM41 (ENSG00000146063), TRIM50 (ENSG00000146755), TRIM4 (ENSG00000146833), TRIM55 (ENSG00000147573), TRIM48 (ENSG00000150244), TRIM36 (ENSG00000152503), TRIM11 (ENSG00000154370), TRIM74 (ENSG00000155428), TRIM42 (ENSG00000155890)

Protein

Protein identifiers

Tripartite motif-containing protein 64CA6NLI5 (reviewed: A6NLI5)

All UniProt accessions (1): A6NLI5

UniProt curated annotations — full annotation on UniProt →

Similarity. Belongs to the TRIM/RBCC family.

RefSeq proteins (1): NP_001193560* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000315Znf_B-boxDomain
IPR001841Znf_RINGDomain
IPR001870B30.2/SPRYDomain
IPR003877SPRY_domDomain
IPR003879Butyrophylin_SPRYDomain
IPR013083Znf_RING/FYVE/PHDHomologous_superfamily
IPR013320ConA-like_dom_sfHomologous_superfamily
IPR017907Znf_RING_CSConserved_site
IPR043136B30.2/SPRY_sfHomologous_superfamily
IPR050143TRIM/RBCCFamily

Pfam: PF00622, PF00643

UniProt features (9 total): binding site 4, zinc finger region 2, chain 1, domain 1, coiled-coil region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-A6NLI5-F184.080.44

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Ligand- & substrate-binding residues (4): 92; 95; 114; 120

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 6 (showing top): GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM, GOMF_ACYLTRANSFERASE_ACTIVITY, GOMF_AMINOACYLTRANSFERASE_ACTIVITY, GOMF_UBIQUITIN_LIKE_PROTEIN_LIGASE_ACTIVITY, GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_INTERSPECIES_INTERACTION_BETWEEN_ORGANISMS, chr11p11

GO Biological Process (2): regulation of gene expression (GO:0010468), innate immune response (GO:0045087)

GO Molecular Function (4): zinc ion binding (GO:0008270), ubiquitin protein ligase activity (GO:0061630), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (1): cytoplasm (GO:0005737)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
gene expression1
regulation of macromolecule biosynthetic process1
immune response1
defense response to symbiont1
transition metal ion binding1
ubiquitin-protein transferase activity1
ubiquitin-like protein ligase activity1
binding1
cation binding1
intracellular anatomical structure1
cellular anatomical structure1

Protein interactions and networks

STRING

144 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TRIM64CTRIM44Q96DX7250
TRIM64CTRIM66O15016249
TRIM64CNAALAD2Q9Y3Q0218
TRIM64CJAK2O60674214
TRIM64CIGFBP3P17936213
TRIM64CFOLH1Q04609199
TRIM64CMTPAPQ9NVV4166
TRIM64CCNOT8Q9UFF9156
TRIM64CRNF181Q9P0P0151
TRIM64CSTAT3P40763138
TRIM64CUBE2BP23567102
TRIM64CUBE2AP49459102
TRIM64CMBD3L5A6NJ0895
TRIM64CMBD3L3A6NE8295
TRIM64CMBD3L2Q8NHZ795

IntAct

2 interactions, top by confidence:

ABTypeScore
TRIM64CCHCHD3psi-mi:“MI:0915”(physical association)0.400

ESM2 similar proteins: A0A3B3IT33, A6NCK2, A6NDI0, A6NGJ6, A6NI03, A6NLI5, C9J1S8, I1YAP6, K7N6K2, P0CI25, P0CI26, P15533, Q0PF16, Q1ACD5, Q1ACD6, Q1ACD7, Q1ACD8, Q2YEM8, Q2YEM9, Q2YEN0, Q2YEN2, Q3ZEE5, Q587N6, Q587N7, Q5BN31, Q5C8T6, Q5C8T8, Q5C8U1, Q5C8U3, Q5C8U4, Q5D7H7, Q5D7H8, Q5D7I0, Q5D7I1, Q5D7I2, Q5D7I3, Q5D7I5, Q5D7I6, Q5D7I9, Q5D7J0

Diamond homologs: A0A3B3IT33, A6NCK2, A6NDI0, A6NGJ6, A6NI03, A6NLI5, B0BLU1, C9J1S8, I1YAP6, O00478, O00481, O15344, O75677, O75678, O75679, O76064, P0CI25, P0CI26, P18892, P19474, P62603, P86448, P86449, Q13410, Q2HJ46, Q3C1V9, Q3TL54, Q4KLN8, Q5EBN2, Q5PQN2, Q5R4I2, Q5R996, Q61510, Q62556, Q6INS5, Q6MFY8, Q6UX41, Q6UXE8, Q6ZWI9, Q7T308

SIGNOR signaling

1 interactions.

AEffectBMechanism
Ub:E2“up-regulates activity”TRIM64Cubiquitination

Disease & clinical

Clinical variants and AI predictions

ClinVar

97 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance94
Likely benign3
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

456 predictions. Top by Δscore:

VariantEffectΔscore
11:49054208:C:CCacceptor_gain1.0000
11:49056355:TCACC:Tdonor_loss1.0000
11:49056356:CA:Cdonor_loss1.0000
11:49056357:A:Cdonor_loss1.0000
11:49056382:C:CCacceptor_gain1.0000
11:49056382:CT:Cacceptor_loss1.0000
11:49056383:T:Cacceptor_loss1.0000
11:49054204:TCCA:Tacceptor_gain0.9900
11:49054205:CCA:Cacceptor_gain0.9900
11:49054205:CCAC:Cacceptor_gain0.9900
11:49054206:CA:Cacceptor_gain0.9900
11:49054206:CAC:Cacceptor_gain0.9900
11:49055408:C:CCacceptor_gain0.9900
11:49056357:A:ACdonor_gain0.9900
11:49056358:C:CCdonor_gain0.9900
11:49056358:CCTTG:Cdonor_gain0.9900
11:49056378:CATC:Cacceptor_gain0.9900
11:49056379:ATC:Aacceptor_gain0.9900
11:49056380:TC:Tacceptor_gain0.9900
11:49056381:CC:Cacceptor_gain0.9900
11:49056385:C:CTacceptor_gain0.9900
11:49058703:AC:Adonor_gain0.9900
11:49058704:CC:Cdonor_gain0.9900
11:49055403:CAGTT:Cacceptor_gain0.9800
11:49056377:ACATC:Aacceptor_gain0.9800
11:49056378:CATCC:Cacceptor_gain0.9800
11:49058704:CCCTG:Cdonor_gain0.9800
11:49058819:AGTCT:Adonor_gain0.9800
11:49054203:ATCCA:Aacceptor_gain0.9700
11:49055406:TT:Tacceptor_gain0.9700

AlphaMissense

3004 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
11:49058807:G:CF102L0.944
11:49058807:G:TF102L0.944
11:49058809:A:GF102L0.944
11:49059011:A:CF34L0.927
11:49059011:A:TF34L0.927
11:49059013:A:GF34L0.927
11:49053837:A:CF410L0.926
11:49053837:A:TF410L0.926
11:49053839:A:GF410L0.926
11:49055314:G:CF285L0.915
11:49055314:G:TF285L0.915
11:49055316:A:GF285L0.915
11:49053807:A:CF420L0.903
11:49053807:A:TF420L0.903
11:49053809:A:GF420L0.903
11:49054059:G:CF336L0.894
11:49054059:G:TF336L0.894
11:49054061:A:GF336L0.894
11:49054038:C:AW343C0.889
11:49054038:C:GW343C0.889
11:49054040:A:GW343R0.887
11:49054040:A:TW343R0.887
11:49054010:A:GW353R0.870
11:49054010:A:TW353R0.870
11:49053735:G:CF444L0.841
11:49053735:G:TF444L0.841
11:49053737:A:GF444L0.841
11:49053771:A:CF432L0.840
11:49053771:A:TF432L0.840
11:49053773:A:GF432L0.840

dbSNP variants (sampled 300 via entrez): RS1000190373 (11:49060393 A>T), RS1000437683 (11:49054695 G>C,T), RS1001191359 (11:49058901 T>C), RS1001222544 (11:49059191 G>A), RS1002273871 (11:49057713 C>A,G,T), RS1003452749 (11:49057271 T>TGCTTCTCTTTC), RS1004587803 (11:49057805 G>A,T), RS1005667299 (11:49056635 C>T), RS1006230756 (11:49055495 G>A), RS1007128801 (11:49060264 T>C), RS1007201581 (11:49053756 G>A,C), RS1007235873 (11:49054052 C>A,T), RS1008094453 (11:49058432 G>A), RS1008542003 (11:49058722 C>A,T), RS1010929594 (11:49057047 C>G,T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

StudyTraitp-value
GCST008759_12Intake of total sugars7.000000e-06
GCST012100_10Hypertrophic cardiomyopathy (sarcomere positive)3.000000e-07

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0010158sugar consumption measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

3 total (human), top 3 by PubMed support.

ChemicalActions (top 5)PubMed papers
hydroxyhydroquinoneincreases expression1
Cadmiumdecreases expression, increases abundance1
Cadmium Chloridedecreases expression, increases abundance1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.